MENU
Back to Top

Scientific Program

The Scientific Program will be finalized shortly. This meeting will vary from past ISSVA Congresses in multiple ways. The “Debates & Updates” meeting will focus on clinical cases and practice, exploring the latest advances in the field through a presentation and debate format, discussing multiple treatment options and philosophies.

Sessions will be recorded and will be available for registered delegates until Wednesday, 30 June 2021. The tentative Live sessions times are listed below.

Preliminary Program

*all sessions and times are listed in the Eastern Time Zone (EDT) and subject to change. To assist with how to convert times to your specific time zone; just click here.

Thursday, 13 May 2021

09:00 - 09:05: Welcome

09:05 - 10:35: Genetics of Vascular Anomalies

  • Genetic Testing in Vascular Malformations
  • Case Presentations 1 – 3
  • Panel Discussion
  • Future Developments in Genetic Testing of Vascular Malformations

10:40 - 12:10: Lymphatic Malformations: Multidisciplinary Approach

  • In utero and Neonatal Management of a Large Cervicofacial LM
  • Case Presentations 1 - 3
  • Panel Discussion: Future Management

12:15 - 13:30: Tribute to Dr. John Mulliken and Social Event

12:30 - 13:30: Exhibit Hall Open

Friday, 14 May 2021

08:00 - 09:00: Exhibit Hall Open

09:00 - 10:30: Coagulation and Thromboembolic Issues in Vascular Anomalies

  • Clinical Overview
  • Case Presentations 1 - 3
  • Panel Discussion
  • Innovations and Future Trends

10:35 - 12:05: Complex AVMs are the Most Challenging VA to Treat

  • Brief Introduction to types of Arteriovenous Malformations
  • Clinical Case on Diagnosis and Treatment Planning - Discussion: The importance of Multidisciplinary Approach
  • Clinical Case Solved Exclusively by IR - Discussion: Potential risks of IR treatment
  • Early Approach to AVM and Outcomes - Discussion: How to predict the best extension of resection
  • Clinical Case on Surgical Treatment - Discussion: Critical time for regrowth
  • Where are we in Pharmacologic Treatment (mTor, MEK inhibitors) - Discussion: Drugs will substitute surgery?

12:05 - 13:00: Exhibit Hall Open

Saturday, 15 May 2021

08:00 - 09:00: Exhibit Hall Open

09:00 - 09:55: Pregnancy and Vascular Malformations (What Should We Tell the Patient? and How to Prevent Complications)

  • Pregnancy and Vascular Malformations
  • AVM’s, Changes during Pregnancy
  • Case Presentations 1-3
  • Panel Discussion

10:00 - 11:25: Hemangiomas and Other Vascular Tumors: Challenging Diagnostic or Management Dilemmas

  • Updates from the Ulcerated Hemangioma Multicenter Study
  • Basic Science Updates - Propranolol: Mechanism of Action - Some Exciting Insights
  • What can we Learn from the PHACE Genetic Registry
  • The Hemangioma Referral Score - A Handy Tool

11:30 - 12:55: Complicated Lymphatic Anomalies (CLA) from Bench to Bedside and Back!

  • A Clinical overview of Complicated Lymphatic Anomalies: Clinical Pearls of Diagnosis and Treatment
  • Case Presentations with Panel Discussion:
    • GLA vs. GSD
    • KLA
    • CCLA
  • Gorham Stout Disease: What is New and Exciting in the Lab?

12:55 - 13:00: Closing Remarks